Other

Lessee Operating Lease Liability Undiscounted Excess Amount

Royalty Pharma Lessee Operating Lease Liability Undiscounted Excess Amount decreased by 15.3% to $2.67M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026

How to read this metric

Changes reflect shifts in the discount rates applied to lease liabilities or changes in the duration of the lease portfolio.

Detailed definition

This represents the difference between the total undiscounted future lease payments and the present value of those payme...

Peer comparison

Comparable across firms with significant real estate or equipment lease portfolios under GAAP.

Metric ID: other_lessee_operating_lease_liability_undiscounted_exce_ce7a69

Historical Data

3 periods
 Q2 '25Q3 '25Q1 '26
Value$3.41M$3.15M$2.67M
QoQ Change—-7.6%-15.3%
Range$2.67M – $3.41M
Current Streak2+ quarters decline

Frequently Asked Questions

What is Royalty Pharma's lessee operating lease liability undiscounted excess amount?
Royalty Pharma (RPRX) reported lessee operating lease liability undiscounted excess amount of $2.67M in Q1 2026.
What does lessee operating lease liability undiscounted excess amount mean?
The difference between the total future lease payments and the present value of those payments on the balance sheet.